Total Payments
$350.87
2024 Payments
$61.56
Companies
11
Transactions
23
Medicare Patients
4,038
Medicare Billing
$450,160
Payment Breakdown by Category
Food & Beverage$350.87 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $350.87 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $71.69 | 4 | $0 (2024) |
| Allergan Inc. | $59.69 | 5 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $49.02 | 3 | $0 (2018) |
| Gilead Sciences Inc | $37.45 | 3 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $36.51 | 2 | $0 (2024) |
| Medtronic, Inc. | $21.88 | 1 | $0 (2024) |
| Phadia US Inc. | $17.58 | 1 | $0 (2018) |
| PFIZER INC. | $17.34 | 1 | $0 (2017) |
| Covidien LP | $16.87 | 1 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $11.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.56 | 3 | ABBVIE INC. ($22.33) |
| 2020 | $19.16 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19.16) |
| 2018 | $74.03 | 5 | Allergan Inc. ($23.77) |
| 2017 | $196.12 | 14 | Gilead Sciences Inc ($37.45) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Gastrointestinal AI | ||||||
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Gastroenterology | ||||||
| 03/17/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Immunology | ||||||
| 09/13/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Allergy/Immunology | ||||||
| 03/09/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/22/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/15/2017 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DELZICOL | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Gastroenterology | ||||||
| 09/22/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/08/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Virology | ||||||
| 08/15/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $11.15 | General |
| 07/31/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Immunology | ||||||
| 07/10/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/18/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $12.40 | General |
| 04/28/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2017 | Covidien LP | PillCam (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: GI Solutions | ||||||
| 03/17/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/03/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 01/13/2017 | PFIZER INC. | PRECEDEX (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: SEDATIVE | ||||||
| 01/09/2017 | Takeda Pharmaceuticals America, Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Upper GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 835 | 883 | $371,247 | $99,694 |
| 2022 | 15 | 817 | 866 | $348,823 | $91,426 |
| 2021 | 18 | 1,059 | 1,123 | $440,283 | $120,546 |
| 2020 | 17 | 1,327 | 1,469 | $492,423 | $138,494 |
Total Patients
4,038
Total Services
4,341
Medicare Billing
$450,160
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $14,023 | $4,971 | 35.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 99 | 125 | $7,875 | $3,781 | 48.0% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $15,200 | $3,348 | 22.0% |
| 43247 | Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $8,588 | $2,755 | 32.1% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 15 | 16 | $13,728 | $2,623 | 19.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 19 | $2,166 | $1,024 | 47.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $5,775 | $204.87 | 3.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 234 | 239 | $120,217 | $21,824 | 18.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 141 | 143 | $34,034 | $13,957 | 41.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 111 | 112 | $66,080 | $12,459 | 18.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 59 | 59 | $28,556 | $11,561 | 40.5% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 66 | 69 | $20,700 | $11,182 | 54.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope via mouth | Facility | 2021 | 21 | 23 | $18,630 | $8,162 | 43.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 49 | 49 | $18,571 | $7,099 | 38.2% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 38 | 40 | $16,920 | $6,429 | 38.0% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 48 | 48 | $21,264 | $6,015 | 28.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 152 | 190 | $11,970 | $5,824 | 48.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope via mouth | Facility | 2021 | 25 | 29 | $24,882 | $4,141 | 16.6% |
| 45382 | Control of bleeding in upper large bowel using an endoscope | Facility | 2021 | 18 | 18 | $17,100 | $3,621 | 21.2% |
| 43244 | Tying of dilated veins of stomach and/or esophagus using an endoscope | Facility | 2021 | 12 | 16 | $8,288 | $3,196 | 38.6% |
| 43247 | Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 13 | 13 | $4,420 | $1,877 | 42.5% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope via mouth | Facility | 2021 | 18 | 19 | $13,642 | $1,064 | 7.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 17 | $1,938 | $984.30 | 50.8% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2021 | 16 | 16 | $4,216 | $692.12 | 16.4% |
| 45381 | Injections beneath lining of large bowel, using a flexible endoscope | Facility | 2021 | 23 | 23 | $8,855 | $459.34 | 5.2% |
About Dr. James Curtiss, MD
Dr. James Curtiss, MD is a Gastroenterology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467442442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Curtiss, MD has received a total of $350.87 in payments from pharmaceutical and medical device companies, with $61.56 received in 2024. These payments were reported across 23 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($350.87).
As a Medicare-enrolled provider, Curtiss has provided services to 4,038 Medicare beneficiaries, totaling 4,341 services with total Medicare billing of $450,160. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Lynchburg, VA
- Active Since 10/21/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467442442
Products in Payments
- ZEPATIER (Drug) $49.02
- LINZESS (Drug) $48.07
- Humira (Biological) $33.05
- VIBERZI (Drug) $22.94
- SKYRIZI (Biological) $22.33
- GI GENIUS (Device) $21.88
- XIFAXAN (Drug) $19.16
- ImmunoCAP (Device) $17.58
- TRULANCE (Drug) $17.35
- PRECEDEX (Drug) $17.34
- PillCam (Device) $16.87
- Mavyret (Drug) $16.31
- Dexilant (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lynchburg
Larry Clark, M.d, M.D
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Mr. Wei Hou, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Ralph Wisniewski, M.d, M.D
Gastroenterology — Payments: $6,349
Gastroenterology $6,349
Robert Richards, M.d, M.D
Gastroenterology — Payments: $4,516
Gastroenterology $4,516
Loretta Maffei, M.d, M.D
Gastroenterology — Payments: $2,537
Gastroenterology $2,537
Charles Catalano, M.d, M.D
Gastroenterology — Payments: $70.52
Gastroenterology $70.52